跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44,330 条关于
“Orphan Drug Act”
全部
44,330
临床试验
18,292
药物
1,416
机构
378
资讯
24,244
去年
FDA Approval of Rival Narcolepsy Treatment Upheld by D.C. Court
去年
Court Upholds FDA's Approval of Avadel's Lumryz Over Jazz's Xywav in Orphan Drug Exclusivity Dispute
去年
Catalyst Pharmaceuticals Secures Patent Settlement with Teva, Extending Firdapse Market Exclusivity Until 2035
去年
Federal Court Strikes Down FDA's Narrow Interpretation of Orphan Drug Exclusivity in Neurelis v. Brenner
去年
US Orphan Drug Market Set to Exceed $190 Billion by 2030 as FDA Designations Accelerate
去年
Promising Pathway Act 2.0 Aims to Expedite Rare Disease Drug Approvals
去年
Court Upholds FDA Approval of Avadel's Lumryz for Narcolepsy, Dismissing Jazz Pharma's Challenge
去年
Court Upholds FDA Approval of Avadel's Once-Nightly Narcolepsy Drug LUMRYZ
去年
LUMRYZ Maintains Market Exclusivity as Court Upholds FDA Approval in Narcolepsy Treatment
2年前
Agios' Tebapivat Receives FDA Orphan Drug Designation for Myelodysplastic Syndromes
第 1 页,共 2425 页
上一页
下一页